PPD brings extensive experience in the nuances of post-approval studies, combined with a solid foundation in late-stage clinical trials management.
Expertise in nearly 40 psychiatric and neurological disorders, and clinically trained neuroscience teams led by scientists and clinicians with extensive neuroscience experience.
PPD's Phase I clinic in Austin, Texas, conducts clinical studies to determine how new medicines act in the bodies of healthy volunteers. This is not testing to determine if the medicine works.
PPD’s Steve Lobel, Carol Olson and Beth Tulip co-authored an article on infectious disease studies in China in the May issue of International Clinical Trials.
PPD News and Events Media kit
© 2013 Pharmaceutical Product Development, LLC. All rights reserved.